Holger Weis

CIK: 0001846984

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)2 (16.7%)

Derivative conversions

Awards (A)10 (83.3%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

TCRT

Alaunos Therapeutics, Inc.

Officer

JUNS

JUPITER NEUROSCIENCES, INC.

Director

Discretionary Trading P&L

Holdings

Transaction History (12 total)

TCRT
Alaunos Therapeutics, Inc.
Oct 6, 2026
Award(A)
Direct
23.6K shares at avg. $0.74$18K
TCRT
Alaunos Therapeutics, Inc.
Aug 6, 2026
Award(A)
Direct
4.4K shares at avg. $2.01$9K
TCRT
Alaunos Therapeutics, Inc.
Jul 23, 2026
Award(A)
Direct
4.6K shares at avg. $1.92$9K
TCRT
Alaunos Therapeutics, Inc.
Jun 30, 2026
Award(A)
Direct
3.9K shares at avg. $2.26$9K
TCRT
Alaunos Therapeutics, Inc.
Jun 12, 2026
Award(A)
Direct
7.8K shares at avg. $2.26$18K
JUNS
JUPITER NEUROSCIENCES, INC.
Jun 2, 2026
Award(A)
Stock Option
Direct
100K shares-
TCRT
Alaunos Therapeutics, Inc.
May 22, 2026
Award(A)
Direct
3.7K shares at avg. $2.37$9K
TCRT
Alaunos Therapeutics, Inc.
Aug 18, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
13.7K shares-
TCRT
Alaunos Therapeutics, Inc.
Jul 2, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
130K shares-
JUNS
JUPITER NEUROSCIENCES, INC.
Jun 2, 2025
Exercise(M)
Direct
85.8K shares-
TCRT
Alaunos Therapeutics, Inc.
Apr 13, 2025
Award(A)
Employee Stock Option (right to buy)
Direct
10.9K shares-
JUNS
JUPITER NEUROSCIENCES, INC.
Jan 22, 2025
Exercise(M)
Direct
10.8K shares-

		Type	Shares	Price		Ownership
Oct 6, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	23,564	$0.74	$17,541	Direct
Aug 6, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	4,363	$2.01	$8,770	Direct
Jul 23, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	4,568	$1.92	$8,771	Direct
Jun 30, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	3,880	$2.26	$8,769	Direct
Jun 12, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	7,761	$2.26	$17,540	Direct
Jun 2, 2026	JUNS JUPITER NEUROSCIENCES, INC.	Award(A) Stock Option	100,000	-	-	Direct
May 22, 2026	TCRT Alaunos Therapeutics, Inc.	Award(A)	3,700	$2.37	$8,769	Direct
Aug 18, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	13,676	-	-	Direct
Jul 2, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	130,000	-	-	Direct
Jun 2, 2025	JUNS JUPITER NEUROSCIENCES, INC.	Exercise(M)	85,800	-	$0	Direct
Apr 13, 2025	TCRT Alaunos Therapeutics, Inc.	Award(A) Employee Stock Option (right to buy)	10,904	-	-	Direct
Jan 22, 2025	JUNS JUPITER NEUROSCIENCES, INC.	Exercise(M)	10,781	-	$0	Direct

1-12 of 12 transactions

About Weis Holger

Weis Holger (SEC CIK 0001846984) files insider reports with the SEC as CEO of Alaunos Therapeutics, Inc. (TCRT) and Director of JUPITER NEUROSCIENCES, INC. (JUNS).

Signal8 holds 13 ownership filings by Weis Holger (1 Form 3, 12 Form 4), filed between Nov 8, 2024 and Oct 8, 2026. Those filings report 12 transactions, from Jan 22, 2025 to Oct 6, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Weis Holger's filings is in FORT LAUDERDALE, FL.

Recent filings by Weis Holger

Oct 6, 2026: Grant or award of TCRT shares (Form 4, code A).
Aug 6, 2026: Grant or award of TCRT shares (Form 4, code A).
Jul 23, 2026: Grant or award of TCRT shares (Form 4, code A).
Jun 30, 2026: Grant or award of TCRT shares (Form 4, code A).
Jun 12, 2026: Grant or award of TCRT shares (Form 4, code A).

Other insiders filing for Alaunos Therapeutics, Inc. (TCRT)

Fairmount Funds Management LLC, Director
Vieser Jaime, Director
Postma Robert W, Director
Jerman Michael Allen, Director
Groenewald Ferdinand, VP, Finance
Hogue Dale Curtis Jr.

How to read Form 4 transaction codes